DISA LIMITED — AGM Information 2025

Oct 9, 2025

==> picture [143 x 144] intentionally omitted <==

DISA Limited Annual General Meeting 24 October 2025

==> picture [157 x 155] intentionally omitted <==

Shared Savings Program (“SSP”)

Current code sales model

▪ Saved approximately US$208 million for retailer since 2017

▪ Covers only approximately 1% of total return fraud

▪ From code sales to SSP

==> picture [181 x 220] intentionally omitted <==

==> picture [36 x 74] intentionally omitted <==

Shared Savings (cont’d) Program (“SSP”)

SSP

==> picture [298 x 255] intentionally omitted <==

• Provides free codes

▪ Share retailers’ savings through the prevention of fraudulent return

▪ Latest update: Working on signing up the lawn, cookware and automotive categories

Visual Screening Medtech

Automated Visual Acuity Test (“ AVAT ”) ▪ Deployed in NUH and a hospital ophthalmology clinic in Hong Kong

• Ongoing trial at Ng Teng Fong General Hospital

• Mobile Imaging Device for Anterior Segment (“ MIDAS ”)

• Ongoing clinical trial with a public hospital ophthalmology clinic in Singapore

==> picture [184 x 168] intentionally omitted <==

==> picture [37 x 74] intentionally omitted <==

ISO 13485-certified AVAT for visual acuity screening

==> picture [232 x 124] intentionally omitted <==

MIDAS for cataract screening

Watch the video at: https://www.canva.com/design/DAG2kypvmko/Vel6WI5pXjRLlGA1FOMQPA/watch

==> picture [763 x 431] intentionally omitted <==

==> picture [37 x 74] intentionally omitted <==

Proposed New Business

(Seeking shareholders’ approval via EGM to be held on 24/10/2025 immediately following the AGM to be held on 24/10/2025 at 10 a.m.)

Integrated Rheumatology Medical and Therapy Centre

==> picture [178 x 177] intentionally omitted <==

ADH Structure

==> picture [217 x 39] intentionally omitted <==

Limited

100%

Advance Digital Healthcare Pte. Ltd. (“ADH”)

The proposed new clinics will be wholly-owned by ADH and operate under the “El Shaddai” brand

==> picture [291 x 43] intentionally omitted <==

50%

Rheumatology Associates Pte. Ltd.

▪ A specialist medical and magnetic therapy centre that focuses on arthritis and rheumatism

Accelerating Chronic Care Needs Amid Asia’s Ageing Boom

Rapidly Ageing Population ▪ 1 in 4 aged 65 and above in Singapore by 2030[(1)]

Prevalence of Aged-Related Chronic Disease ▪ Mobility and visual ailments

High Demand for the Treatment of Chronic Ailments ▪ Underdiagnosis and underserved

(1) https://www.population.gov.sg/our-population/population-trends/longevity/

==> picture [80 x 43] intentionally omitted <==

Mobility Healthcare

A One-Stop Solution: From Consultation to Treatment and Therapy

• Integrated chronic care services

• AI-driven solutions for knee osteoarthritis

• Heartland-based medical and therapy centre — accessible and community-focused care

==> picture [165 x 129] intentionally omitted <==

==> picture [172 x 133] intentionally omitted <==

==> picture [101 x 134] intentionally omitted <==

==> picture [87 x 68] intentionally omitted <==

==> picture [83 x 66] intentionally omitted <==

AI Guided Diagnosis

Treatment Hyaluronic acid injection

Magnetic Therapy

==> picture [143 x 144] intentionally omitted <==

==> picture [178 x 33] intentionally omitted <==

DISA Limited

==> picture [35 x 37] intentionally omitted <==

==> picture [36 x 34] intentionally omitted <==

Thank You

==> picture [80 x 43] intentionally omitted <==

==> picture [157 x 155] intentionally omitted <==

This presentation does not constitute, or form any part of any offer for sale or subscription of, or solicitation of any offer to buy or subscribe for, any securities in DISA Limited (“DISA”) in Singapore or any other jurisdiction nor shall it or any part of it form the basis of, or be relied on in connection with, any investment decision, contract or commitment whatsoever in this or any jurisdiction. This presentation may contain forward-looking statements that involve assumptions, risks and uncertainties. Actual future performance, outcomes and results may differ materially from those expressed in forward-looking statements as a result of a number of risks, uncertainties and assumptions. You are cautioned not to place undue reliance on these forward-looking statements, if any, which are based on the current view of management on future events. The information contained in this presentation has not been independently verified. No representation or warranty expressed or implied is made as to, and no reliance should be placed on, the fairness, accuracy, completeness or correctness of the information or opinions contained in this presentation. Neither DISA or any of its affiliates, advisers or representatives shall have any liability whatsoever (in negligence or otherwise) for any loss howsoever arising, whether directly or indirectly, from any use, reliance or distribution of this presentation or its contents or otherwise arising in connection with this presentation.

This presentation have been reviewed by the Company’s Sponsor, SAC Capital Private Limited (“Sponsor”).

This presentation has not been examined or approved by the Singapore Exchange Securities Trading Limited (“SGXST”) and the SGX-ST assumes no responsibility for the contents of this presentation including the correctness of any of the statements or opinions made or reports contained in this presentation.

The contact person for the Sponsor is Ms. Lee Khai Yinn (Registered Professional, SAC Capital Private Limited). Address: 1 Robinson Road #21-01 AIA Tower, Singapore 048542. Telephone number: +65 6232 3210